By proceeding, you agree to our Terms of Use and Privacy Policy.
Scientist, Co-Founder
#crispr #bioinformatics #molecularbiology
#NorthAmerica
Experienced CRISPR scientist with a demonstrated history of developing novel gene editing systems. Skilled in CRISPR, Bioinformatics, AWS, Microbiology, and Molecular Biology.
Chief Technology Officer and Head of Platform
#crispr #protac #biotech #proteostasis #drugdiscovery
#Europe
Ben is Chief Technology Officer (CTO) at PhoreMost, a target identification and drug discovery company based in Cambridge, UK. He joined in 2019 to lead the evolution and development of a novel screen
Chief Executive Officer
#crispr #cellularbiology #geneticengineering
Benjamin L. Oakes is the co-founder, President, and Chief Executive Officer at Scribe Therapeutics, a molecular engineering company focused on creating best-in-class in vivo therapies that permanently
Chief Medical Officer
#crispr #celltherapy #genetherapy #medicalaffairs #clinicaldevelopment
#Northamerica
Physician, immunologist and molecular biologist with extensive global leadership experience in clinical research and development, translational medicine, business development and medical affairs.